Use of mTOR inhibitors in the treatment of malignancies

By Mohindra Nisha A   Giles Francis J   Platanias Leonidas C  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 7, 2014-05 ,pp. : 979-990

Informa Healthcare

Access to resources Recommend Favorite

Insights into melanoma: targeting the mTOR pathway for therapeutics

By Pópulo Helena   Soares Paula   Lopes José Manuel  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 7, 2012-07 ,pp. : 689-705

Informa Healthcare

Access to resources Recommend Favorite

Targeting mTOR Signaling Pathway in Ovarian Cancer

By  

Current Medicinal Chemistry, Vol. 18, Iss. 19, 2011-06 ,pp. : 2960-2968

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the mTOR Pathway in Tumor Malignancy

By  

Current Cancer Drug Targets, Vol. 13, Iss. 3, 2013-03 ,pp. : 267-277

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the PI3K/AKT/mTOR Signaling Axis in Children with Hematologic Malignancies

By Barrett David   Brown Valerie I.   Grupp Stephan A.   Teachey David T.  

Pediatric Drugs, Vol. 14, Iss. 5, 2012-10 ,pp. : 299-316

Adis International

Access to resources Recommend Favorite